Researchers found that the COVID-19 pandemic reversed the gains made in the treatment of TB globally and in South Africa. CAPRISA Director Professor Salim Abdool Karim elaborates.
We use cookies to make your experience with us better. By continuing to use our website, you are agreeing to our use of cookies. To find out more see our privacy policy.